Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch

Published:2012-10-16 Issue:1 Volume:13 Page:76-85
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Bentall A.,Cornell L. D.¹,Gloor J. M.²,Park W. D.³,Gandhi M. J.⁴,Winters J. L.⁴,Chedid M. F.³,Dean P. G.³,Stegall M. D.³

Affiliation:

1. Division of Anatomic Pathology; von Liebig Transplant Center; Mayo Clinic; Rochester; MN

2. Division of Nephrology and Hypertension; von Liebig Transplant Center; Mayo Clinic; Rochester; MN

3. Division of Transplantation Surgery; von Liebig Transplant Center; Mayo Clinic; Rochester; MN

4. Division of Transfusion Medicine; von Liebig Transplant Center; Mayo Clinic; Rochester; MN

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2012.04291.x/fullpdf

Reference23 articles.

1. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: Posttransplant analysis using flow cytometric techniques;Piazza;Transplantation,2001

2. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts;Lachmann;Transplantation,2009

3. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients;Jordan;Transplantation,2003

4. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients;Montgomery;Transplantation,2000

5. Overcoming a positive crossmatch in living-donor kidney transplantation;Gloor;Am J Transplant,2003

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous combined transplantation: Intricacies in immunosuppression management;Transplantation Reviews;2024-12

2. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

3. Prolonged xenokidney graft survival in sensitized NHP recipients by expression of multiple human transgenes in a triple knockout pig;Science Translational Medicine;2024-06-12

4. Challenges and opportunities for designing clinical trials for antibody mediated rejection;Frontiers in Transplantation;2024-06-12

5. Imlifidase: Is it the Magic Wand in Renal Transplantation?;Indian Journal of Nephrology;2024-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3